116 related articles for article (PubMed ID: 10443019)
1. 2-[4-[3-(4-aryl/heteroaryl-1-piperazinyl)propoxy]phenyl]-2H- benzotriazoles and their N-oxides as ligands for serotonin and dopamine receptors.
Sparatore A; Goegan M; Cagnotto A; Sparatore F
Farmaco; 1999 Jun; 54(6):402-10. PubMed ID: 10443019
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of aryl/heteroaryl piperazinyl alkyl benzotriazoles as ligands for some serotonin and dopamine receptor subtypes.
Boido A; Boido CC; Sparatore F
Farmaco; 2001 Apr; 56(4):263-75. PubMed ID: 11421254
[TBL] [Abstract][Full Text] [Related]
3. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands.
Laszlovszky I; Acs T; Kiss B; Domány G
Pharmazie; 2001 Apr; 56(4):287-9. PubMed ID: 11338664
[TBL] [Abstract][Full Text] [Related]
4. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
Kostić-Rajacić S; Soskić V; Joksimović J
Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
[TBL] [Abstract][Full Text] [Related]
6. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
[TBL] [Abstract][Full Text] [Related]
7. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J
J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724
[TBL] [Abstract][Full Text] [Related]
8. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
Dukić S; Vujović M; Soskić V; Joksimović J
Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
[TBL] [Abstract][Full Text] [Related]
9. A search for new 5-HT1A/5-HT2A receptor ligands. In vitro and in vivo studies of 1-[omega-(4-aryl-1-piperazinyl)alkyl]indolin-2(1H)-ones.
Mokrosz MJ; Duszyńska B; Misztal S; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Dziedzicka-Wasylewska M
Arch Pharm (Weinheim); 1998 Oct; 331(10):325-30. PubMed ID: 9844580
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
Dukić S; Kostić-Rajacić S; Dragović D; Soskić V; Joksimović J
J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
[TBL] [Abstract][Full Text] [Related]
11. C5-substituted derivatives of 5-OMe-BPAT: synthesis and interactions with dopamine D2 and serotonin 5-HT1A receptors.
Homan EJ; Tulp MT; Nilsson JE; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Nov; 7(11):2541-8. PubMed ID: 10632064
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
Kostic-Rajacic A; Soskic V; Joksimovic J
Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, 5-HT1A and 5-HT2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2,6- and pyrrolidine-2,5-diones.
Pawłowski M; Chłoń G; Obniska J; Zejc A; Charakchieva-Minol S; Mokrosz MJ
Farmaco; 2000; 55(6-7):461-8. PubMed ID: 11204747
[TBL] [Abstract][Full Text] [Related]
15. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
[TBL] [Abstract][Full Text] [Related]
16. Mixed dopaminergic/serotonergic properties of several 2-substituted 4-[2-(5-benzimidazole)ethyl]-1-arylpiperazines.
Kostic-Rajacic S; Soskic V; Joksimovic J
Arch Pharm (Weinheim); 1998 Jan; 331(1):22-6. PubMed ID: 9507698
[TBL] [Abstract][Full Text] [Related]
17. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
18. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a methyl group in alpha- or beta-position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties.
Roglic G; Andric D; Kostic-Rajacic S; Dukic S; Soskic V
Arch Pharm (Weinheim); 2001 Dec; 334(12):375-80. PubMed ID: 11852532
[TBL] [Abstract][Full Text] [Related]
20. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
